PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34175720-4	2021	Doxorubicin as a universal anticancer drug and sorafenib as a potent VEGFR-2 inhibitor were used as positive controls.	Sorafenib	47-56	kinase insert domain receptor	Homo sapiens	69-76	
34175720-12	2021	Compounds 15 and 17b potently inhibited VEGFR-2 at lower IC50 values of 1.09 and 1.19 microM, respectively, compared to sorafenib (IC50 = 1.27 microM).	Sorafenib	120-129	kinase insert domain receptor	Homo sapiens	40-47